Please login to the form below

Not currently logged in
Email:
Password:

EBE

This page shows the latest EBE news and features for those working in and with pharma, biotech and healthcare.

Industry welcomes European diagnostics regulations

Industry welcomes European diagnostics regulations

scandal. The European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) voiced qualified support for the new IVD regulations. ... Barbara Freischem, executive director of EBE, commented:

Latest news

  • EMA on track with biosimilars guidance says industry EMA on track with biosimilars guidance says industry

    Trade organisations the European Biopharmaceutical Enterprises (EBE) and EuropaBio believe the planned revisions "offer important developments to further strengthen the biosimilars pathway in Europe", according to Eugene Corretge, strategic unit

  • Orphan drug legislation hailed as success

    Legislation governing Orphan Medicinal Products in Europe has had a positive impact, according to a joint EBE and EuropaBio task force. ... EBE (European Biopharmaceutical Enterprises) and EuropaBio's Joint Rare Diseases and Orphan Medicinal Products

  • What is EFPIA...

    EFPIA has two specialist groups to address specific issues. The European Vaccine Manufacturers (EVM) covers vaccine topics, while European Biotechnology Enterprises (EBE) deals with the needs of biopharmaceutical sector companies.

  • The mothership

    Therefore please make your contributions to your European Trade Association; be it EVM for vaccine manufacturers, Eucomed for medical device manufacturers, EBE for upcoming biopharmaceutical companies, or the mothership itself, EFPIA,

  • A model approach A model approach

    The European Biopharmaceutical Enterprises (EBE) has requested that the EC and the EMEA issue guidance and clarify the concepts of 'similarity', 'interchangeability' and 'substitution'. ... The EBE considers this to be crucial for industry and healthcare

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Eduardo Bravo becomes head of EBE Eduardo Bravo becomes head of EBE

    TiGenix CEO appointed president of the EBE’s board of directors. The European Biopharmaceutical Enterprises (EBE) has appointed Eduardo Bravo as president of its board of directors for the 2016-2018 ... 2011. Barbara Freischem, EBE's executive director,

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...